Inhibitory Effect of Human Natural Yeast Killer Toxin-like Candidacidal Antibodies on Pneumocystis carinii

Molecular Medicine

Volumn 3, Issue 8, 1997, Pages 544-552

  Séguy, Nathalie ^a   Cailliez, Jean Charles ^a,b   Delcourt, Philippe ^a   Conti, Stefania ^c   Camus, Daniel ^a,d   Dei Cas, Eduardo ^d,e   Polonelli, Luciano ^c  

^a INSERM   (France)

^b UNIVERSITÉ CATHOLIQUE DE LILLE   (France)

^c UNIVERSITY OF PARMA   (Italy)

^d Center Hospitalier et Universitaire   (France)

^e INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; FUNGUS ANTIBODY; KILLER FACTOR, YEAST; MONOCLONAL ANTIBODY; MYCOTOXIN;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; CANDIDA; CELL ADHESION; FEMALE; FIBROBLAST; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; ISOLATION AND PURIFICATION; LUNG; MALE; METABOLISM; MICROBIOLOGY; NUDE RAT; PNEUMOCYSTIS; PNEUMOCYSTIS PNEUMONIA; RAT; SERODIAGNOSIS; VAGINA; VAGINA CANDIDIASIS;

ANIMALS; ANTIBODIES, FUNGAL; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CANDIDA; CANDIDIASIS, VULVOVAGINAL; CELL ADHESION; FEMALE; FIBROBLASTS; HUMANS; IMMUNITY, NATURAL; LUNG; MALE; MYCOTOXINS; NEUTRALIZATION TESTS; PNEUMOCYSTIS; PNEUMONIA, PNEUMOCYSTIS; RATS; RATS, NUDE; RECEPTORS, CELL SURFACE; VAGINA;

EID: 0031205621     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401700     Document Type: Article

References (34)

1. Sattler FR, Jelliffe RW. (1994) Pharmacokinetic and pharmacodynamic considerations for drug dosing in the treatment of Pneumocystis carinii pneumonia. In: Walzer PD (ed). Pneumocystis carinii Pneumonia, 2nd ed., Vol. 69. Marcel Dekker, New York, pp. 467-485.
2. Aliouat EM, Cailliez JC, Séguy N, et al. (1993) Inhibitory effect of a yeast killer toxin to the in vitro Pneumocystis carinii attachment. Serodiagn. Immunother. Infect. Dis. 5: 102-106.
3. Séguy N, Aliouat EM, Dei-Cas E, Polonelli L, Camus D, Cailliez JC. (1994) Susceptibility of Pneumocystis carinii to a Pichia anomala killer toxin. J. Eukaryot. Microbiol. 41: 109S.
4. Séguy N, Cailliez JC, Polonelli L, Dei-Cas E, Camus D. (1996) Inhibitory effect of a Pichia anomala killer toxin on Pneumocystis carinii infectivity to the SCID mouse. Parasitol. Res. 82: 114-116.
5. Conti S, Cantelli C, Gerloni M, et al. (1996) Killer factor interference in mixed opportunistic yeast cultures. Mycopathologia 135: 1-8.
6. Polonelli L, Conti S, Gerloni M, Magliani W, Chezzi C, Morace G. (1991) Interfaces of the yeast killer phenomenon. Crit. Rev. Microbiol. 8: 47-87.
7. Cailliez JC, Séguy N, Aliouat EM, Polonelli L, Camus D, Dei-Cas E. (1994) The yeast killer phenomenon: A hypothetical way to control Pneumocystis carinii pneumonia. Med. Hypotheses 43: 167-171.
8. Polonelli L, Morace G. (1988) Yeast killer toxin-like anti-idiotypic antibodies. J. Clin. Microbiol. 26: 602-604.
9. Polonelli L, Lorenzini F, DeBernardis F, et al. (1993) Idiotypic vaccination: Immunoprotection mediated by anti-idiotypic antibodies with antibiotic activity. Scand. J. Immunol. 37: 105-110.
10. Polonelli L, De Bernardis F, Conti S, et al. (1994) Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies. J. Immunol. 152: 3175-3182.
11. Polonelli L, Conti S, Gerloni M, et al. (1991) 'Antibiobodies': Antibiotic-like antiidiotypic antibodies. J. Med. Vet. Mycol. 29: 235-242.
12. Polonelli L, Fanti F, Conti S, et al. (1990) Detection by immunofluorescent anti-idiotypic antibodies of yeast killer toxin cell wall receptors of Candida albicans. J. Immunol. Methods 132: 205-209.
13. Polonelli L, De Bernardis F, Conti S, et al. (1996) Human natural yeast killer toxin-like candidacidal antibodies. J. Immunol. 156: 1880-1885.
14. Cassone A, Conti S, De Bernardis F, Polonelli L. (1997) Antibodies, killer toxins and antifungal immunoprotection: A lesson from nature? Immunol. Today 18: 164-169.
15. Polonelli L, Morace G. (1987) Production and characterization of yeast killer toxin monoclonal antibodies. J. Clin. Microbiol. 25: 460-462.
16. Séguy N, Polonelli L, Conti S, Dei-Cas E, Camus D, Cailliez JC. (1996) In vitro decrease of rat-derived Pneumocystis carinii attachment induced by human natural yeast killer toxin-like antiidiotypic candidacidal antibodies. J. Eukaryot. Microbiol. 43: 27S.
17. Allouat EM, Dei-Cas E, Billaut P, Dujardin L, Camus D. (1995) Pneumocystis carinii organisms from in vitro culture are highly infectious to the nude rat. Parasitol. Res. 81: 82-85.
18. Magliani W, Conti S, De Bernardis F, et al. (1997) Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity. Nat. Biotechnol. 15: 155-158.
19. Polonelli L, Séguy N, Conti S, et al. (1997) Monoclonal yeast killer toxin-like candidacidal antiidiotypic antibodies. Clin. Diagn. Lab. Immunol. 4: 142-146.
20. Cailliez JC, Séguy N, Denis CM, et al. (1996) Pneumocystis carinii: An atypical fungal microorganism. J. Med. Vet. Mycol. 34: 227-239.
21. Edman JC, Sogin ML. (1994) Molecular phylogenic of Pneumocystis carinii. In: Pneumocystis carinii Pneumonia, 2nd ed., New York, Marcel Dekker, Vol. 69. pp. 91-106.
22. Stringer JR, Edman JC, Cushion MT, Richards FF, Watanabe J. (1992) The fungal nature of Pneumocystis carinii. J. Med. Vet. Mycol. 30: 271-278.
23. Wakefield AE, Peters SE, Banerji S, Bridge PD, Hopkin JM. (1992) Pneumocystis carinii shows DNA homology with the Ustomycetous Red yeast fungi. Mol. Microbiol. 6: 1903-1911.
24. Walzer PD. (1991) Pneumocystis carinii - New clinical spectrum? New Engl. J. Med. 324: 263-265.
25. Beck JM, Liggitt HD, Brunette EN, Fuchs HJ, Shellito JE, Debs RJ. (1991) Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon. Infect. Immunol. 59: 3859-3862.
26. Ezekowitz RAB, Williams DJ, Koziel H, et al. (1991) Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature 351: 155-158.
27. Su TH, Martin WJ. (1994) Pathogenesis and host response in Pneumocystis carinii pneumonia. Annu. Rev. Med. 45: 261-272.
28. Schmatz D, Romancheck M, Pittarelli L, et al. (1990) Treatment of Pneumocystis carinii with 1,3-glucan synthesis inhibitors. Proc. Natl. Acad. Sci. USA 87: 5950-5954.
29. Matsumoto Y, Matsuda S, Tegashi T. (1989) Yeast glucan in the cyst wall of Pneumocystis carinii. J. Protozool. 36: 21S-24S.
30. Sawant AD, Ahearn DG. (1990) Involvement of a cell wall receptor in the mode of action of an anti-Candida toxin of Pichia anomala. Antmicrob. Agents Chemother. 34: 1331-1335.
31. Polonelli L, Morace G. (1986) Reevaluation of the yeast killer phenomenon. J. Clin. Microbiol. 24: 866-869.
32. Magliani W, Conti S, Gerloni M, Bertolotti D, Polonelli L. (1997) Yeast killer systems. Clin. Microbiol. Rev. 10: 369-400.
33. Kovacs JA, Halpern JL, Lungren B, Swan JC, Parrillo JE, Masur H. (1989) Monoclonal antibodies to Pneumocystis carinii: Identification of specific antigens and characterization of antigenic differences between rat and human isolates. J. Infect. Dis. 159: 60-70.
34. Mazars E, Ödberg-Ferragut C, Dei-Cas E, et al. (1995) Polymorphism of the thymidylate synthase gene of Pneumocystis carinii from different host species. J. Eukaryot. Microbiol. 42: 26-32.